These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12016800)

  • 1. [Study on the antidiuretic efficacy and mechanism of indapamide in central diabetes insipidus].
    Peng H; Zhou Z; Zhao W; Wu H
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(3):259-62. PubMed ID: 12016800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical trial of indapamide in the management of central diabetes insipidus].
    Zhou ZG; Luo HB; Tang WL
    Zhonghua Nei Ke Za Zhi; 1994 Oct; 33(10):661-2. PubMed ID: 7712910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].
    Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G
    Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of indapamide in central diabetes insipidus.
    Tetiker T; Sert M; Koçak M
    Arch Intern Med; 1999 Sep; 159(17):2085-7. PubMed ID: 10510995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible induction of diabetes by treatment of hypertension with indapamide (with four case reports).
    Jian-Liang Z; Yong-Wen Q; Xing Z; Jian-Li Q; Jiang C; Rong-Liang X
    Diabetes Res Clin Pract; 2004 Sep; 65(3):243-6. PubMed ID: 15331204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
    Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
    Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of idiopathic hypercalciuria with indapamide.
    Lemieux G
    CMAJ; 1986 Jul; 135(2):119-21. PubMed ID: 3719496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidiuretic effect of indapamide in central diabetes insipidus.
    Koçak M; Karademir BM; Tetiker T
    Acta Endocrinol (Copenh); 1990 Dec; 123(6):657-60. PubMed ID: 2284890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of valsartan and indapamide on plasma cytokines in essential hypertension.
    Xie QY; Wang YJ; Sun ZL; Yang TL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):629-34. PubMed ID: 17062919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of indapamide on the renin-aldosterone system, and urinary excretion of potassium and calcium in essential hypertension.
    Danielsen H; Pedersen EB; Spencer ES
    Br J Clin Pharmacol; 1984 Aug; 18(2):229-31. PubMed ID: 6386023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
    Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H
    Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trauma-induced central diabetes insipidus in a cat.
    Campbell FE; Bredhauer B
    Aust Vet J; 2008 Mar; 86(3):102-5. PubMed ID: 18304048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of medium term indapamide treatment in hypertensive diabetic patients.
    Byam N; Patrick AL
    West Indian Med J; 1985 Dec; 34(4):261-4. PubMed ID: 4090473
    [No Abstract]   [Full Text] [Related]  

  • 17. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
    Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
    J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
    Marre M; Garcia Puig J; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Pozza G; Chastang C; Ollivier JP; Amouyel P; Asmar R
    J Hypertens Suppl; 2003 Mar; 21(1):S19-24. PubMed ID: 12769163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and vascular effects of ACE inhibitor enalapril in combination with thiaside-like diuretic indapamide in hypertensive outpatients. Results of the multicenter trial POEMA].
    Belenkov IuN; Ageev FT; Orolova IaA; Abrosimova OIu; Volkova EG; Gapon LI; Katel'nitskaia LI; Kondari AO; Patrusheva IF; Fomin IV; Khokhlov RA
    Ter Arkh; 2007; 79(8):33-8. PubMed ID: 17926468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long term therapy of essential hypertension with indapamide: studies on the effect on electrolyte balance and glucose metabolism].
    Zorn J
    Fortschr Med; 1980 Dec; 98(46):1836-40. PubMed ID: 7274922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.